Comparison of facility and home-based antiretroviral therapy delivery systems in Uganda

Comparison of facility and home-based antiretroviral therapy delivery systems in Uganda: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17184129

Enrollment

1000

Registered

2005-09-26

Start date

2005-02-15

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) Infections and Infestations Human immunodeficiency virus

Interventions

A comparison of two different ways of providing ART in an African setting - home-based versus facility-based HIV care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All HIV-infected adults (aged 18 years or more) who are started on antiretroviral therapy (ART) by a service provider (The acquired immunodeficiency syndrome [AIDS] Support Organisation) and who plan to remain in the study area for 12 months.

Exclusion criteria

Exclusion criteria: 1. Already on ART and transferred from another centre 2. Live on islands and are difficult to follow-up

Design outcomes

Primary

Measure	Time frame
Time to detectable viral load	—

Secondary

Measure	Time frame
1. Adherence 2. Cost effectiveness 3. Treatment failure	—

Countries

Uganda

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026